These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 34097307)

  • 1. Phase 2 Study of Adjuvant Radiotherapy Following Narrow-Margin Hepatectomy in Patients With HCC.
    Chen B; Wu JX; Cheng SH; Wang LM; Rong WQ; Wu F; Wang SL; Jin J; Liu YP; Song YW; Ren H; Fang H; Tang Y; Li N; Li YX; Wang WH
    Hepatology; 2021 Nov; 74(5):2595-2604. PubMed ID: 34097307
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Survival benefit with IMRT following narrow-margin hepatectomy in patients with hepatocellular carcinoma close to major vessels.
    Wang WH; Wang Z; Wu JX; Zhang T; Rong WQ; Wang LM; Jin J; Wang SL; Song YW; Liu YP; Ren H; Fang H; Wang WQ; Liu XF; Yu ZH; Li YX
    Liver Int; 2015 Dec; 35(12):2603-10. PubMed ID: 25939444
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Postoperative adjuvant treatment strategy for hepatocellular carcinoma with microvascular invasion: a non-randomized interventional clinical study.
    Wang L; Wang W; Rong W; Li Z; Wu F; Liu Y; Zheng Y; Zhang K; Siqin T; Liu M; Chen B; Wu J
    BMC Cancer; 2020 Jul; 20(1):614. PubMed ID: 32611327
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Partial hepatectomy with wide versus narrow resection margin for solitary hepatocellular carcinoma: a prospective randomized trial.
    Shi M; Guo RP; Lin XJ; Zhang YQ; Chen MS; Zhang CQ; Lau WY; Li JQ
    Ann Surg; 2007 Jan; 245(1):36-43. PubMed ID: 17197963
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of Adjuvant Radiation Therapy With Long-Term Overall and Recurrence-Free Survival After Hepatectomy for Hepatocellular Carcinoma: A Multicenter Propensity-Matched Study.
    Gou XX; Shi HY; Li C; Chen ZL; Ouyang W; Sun LY; Diao YK; Wang MD; Yao LQ; Gu LH; Pawlik TM; Lau WY; Shen F; Xue J; Yang T
    Int J Radiat Oncol Biol Phys; 2022 Oct; 114(2):238-249. PubMed ID: 35643251
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Surgical Margin Affects the Long-Term Prognosis of Patients With Hepatocellular Carcinoma Undergoing Radical Hepatectomy Followed by Adjuvant TACE.
    Bai S; Yang P; Liu J; Xue H; Xia Y; Liu F; Yang Z; Zhang L; Wu Y; Shen F; Wang K
    Oncologist; 2023 Aug; 28(8):e633-e644. PubMed ID: 37029989
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Postoperative adjuvant IMRT for patients with HCC and portal vein tumor thrombus: An open-label randomized controlled trial.
    Sun J; Yang L; Shi J; Liu C; Zhang X; Chai Z; Lau WY; Meng Y; Cheng SQ
    Radiother Oncol; 2019 Nov; 140():20-25. PubMed ID: 31176205
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adjuvant Transarterial chemoembolization does not influence recurrence-free or overall survival in patients with combined hepatocellular carcinoma and Cholangiocarcinoma after curative resection: a propensity score matching analysis.
    Liu WR; Tian MX; Tao CY; Tang Z; Zhou YF; Song SS; Jiang XF; Wang H; Zhou PY; Qu WF; Fang Y; Ding ZB; Zhou J; Fan J; Shi YH
    BMC Cancer; 2020 Jul; 20(1):642. PubMed ID: 32650743
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Survival benefit of radiotherapy following narrow-margin hepatectomy in patients with hepatocellular carcinoma: A propensity score-matched analysis based on phase II study.
    Long L; Chen B; Wang H; Zhao Y; Wu F; Wang L; Rong W; Wu J; Li Y; Wang W
    Radiother Oncol; 2023 Mar; 180():109462. PubMed ID: 36634853
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of postoperative adjuvant transcatheter arterial chemoembolization in hepatocellular carcinoma patients with microvascular invasion.
    Ye JZ; Chen JZ; Li ZH; Bai T; Chen J; Zhu SL; Li LQ; Wu FX
    World J Gastroenterol; 2017 Nov; 23(41):7415-7424. PubMed ID: 29151695
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Surgical treatment of primary liver cancer:a report of 10 966 cases].
    Xia YX; Zhang F; Li XC; Kong LB; Zhang H; Li DH; Cheng F; Pu LY; Zhang CY; Qian XF; Wang P; Wang K; Wu ZS; Lyu L; Rao JH; Wu XF; Yao AH; Shao WY; Fan Y; You W; Dai XZ; Qin JJ; Li MY; Zhu Q; Wang XH
    Zhonghua Wai Ke Za Zhi; 2021 Jan; 59(1):6-17. PubMed ID: 33412628
    [No Abstract]   [Full Text] [Related]  

  • 12. Clinical efficacy of postoperative adjuvant transcatheter arterial chemoembolization on hepatocellular carcinoma.
    Liu C; Sun L; Xu J; Zhao Y
    World J Surg Oncol; 2016 Apr; 14():100. PubMed ID: 27038790
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Minor versus major hepatic resection for small hepatocellular carcinoma (HCC) in cirrhotic patients: a 20-year experience.
    Dahiya D; Wu TJ; Lee CF; Chan KM; Lee WC; Chen MF
    Surgery; 2010 May; 147(5):676-85. PubMed ID: 20004441
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term results of a randomized, observation-controlled, phase III trial of adjuvant interferon Alfa-2b in hepatocellular carcinoma after curative resection.
    Chen LT; Chen MF; Li LA; Lee PH; Jeng LB; Lin DY; Wu CC; Mok KT; Chen CL; Lee WC; Chau GY; Chen YS; Lui WY; Hsiao CF; Whang-Peng J; Chen PJ;
    Ann Surg; 2012 Jan; 255(1):8-17. PubMed ID: 22104564
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Influence of surgical resection margin in hepatectomy on survival of patients with hepatocellular carcinoma].
    Xu L; Shi M; Zhang YQ; Li JQ
    Zhonghua Zhong Liu Za Zhi; 2006 Jan; 28(1):47-9. PubMed ID: 16737621
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A randomized controlled trial of hepatectomy with adjuvant transcatheter arterial chemoembolization versus hepatectomy alone for Stage III A hepatocellular carcinoma.
    Zhong C; Guo RP; Li JQ; Shi M; Wei W; Chen MS; Zhang YQ
    J Cancer Res Clin Oncol; 2009 Oct; 135(10):1437-45. PubMed ID: 19408012
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phase 2 Evaluation of Neoadjuvant Intensity-Modulated Radiotherapy in Centrally Located Hepatocellular Carcinoma: A Nonrandomized Controlled Trial.
    Wu F; Chen B; Dong D; Rong W; Wang H; Wang L; Wang S; Jin J; Song Y; Liu Y; Fang H; Tang Y; Li N; Zhu X; Li Y; Wang W; Wu J
    JAMA Surg; 2022 Dec; 157(12):1089-1096. PubMed ID: 36197682
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adjuvant transarterial chemoembolization after curative resection of hepatocellular carcinoma: a non-randomized comparative study.
    Xi T; Lai EC; Min AR; Shi LH; Wu D; Xue F; Wang K; Yan Z; Xia Y; Shen F; Lau WY; Wu MC
    Hepatogastroenterology; 2012 Jun; 59(116):1198-203. PubMed ID: 22580673
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of Surgical Margin Width on Patterns of Recurrence among Patients Undergoing R0 Hepatectomy for T1 Hepatocellular Carcinoma: An International Multi-Institutional Analysis.
    Tsilimigras DI; Sahara K; Moris D; Hyer JM; Paredes AZ; Bagante F; Merath K; Farooq AS; Ratti F; Marques HP; Soubrane O; Azoulay D; Lam V; Poultsides GA; Popescu I; Alexandrescu S; Martel G; Guglielmi A; Hugh T; Aldrighetti L; Endo I; Pawlik TM
    J Gastrointest Surg; 2020 Jul; 24(7):1552-1560. PubMed ID: 31243714
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic factors of disease-free and overall survival in patients with hepatocellular carcinoma undergoing partial hepatectomy in curative intent.
    Lurje G; Bednarsch J; Czigany Z; Amygdalos I; Meister F; Schöning W; Ulmer TF; Foerster M; Dejong C; Neumann UP
    Langenbecks Arch Surg; 2018 Nov; 403(7):851-861. PubMed ID: 30267147
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.